some idea of the spontaneous variation to be expected. When this was allowed for, the measurements made in the six laboratories were reasonably comparable, with the exception of TLco and RAW in Case 1. In the five laboratories where TLco was measured by the single-breath method it varied from 10.5 to 20.4 ml CO/min/mmHg against a predicted normal of 26. Kco was calculated in three laboratories, and was normal for the two highest readings of TLco and low on the third occasion. The presence of the word emphysema in the report was markedly dependent on the value of TLco obtained. If it is accepted that a low transfer factor (perhaps corrected for alveolar volume) tends to indicate the presence of emphysema in a patient with chronic airways obstruction, then some of these results were wrong. If on the other hand they represent true spontaneous variation then it is unlikely that the measurement can be used to detect a non-labile pathological condition.
A study of repeatability of TLco in patients with chronic airways obstruction is clearly required. RAW in Case 1 was found to be 5.6, 3.7, and 7.3 cmH2O/(l/s). While this variation may have been real, experience of this man's flow-pressure loops leads me to suspect that there was much scope for observer variation. In two laboratories the measurement was quoted to three decimal places, eg. 3.745 cmH2O/(l/s). Two laboratories quoted the wrong units and the third did not quote the units at all. In Case 2, RAW was quoted as 1.569, 1.618, and 0 (sic) respectively. Five laboratories quoted predicted normal values and three gave their results as such and also as a percentage of the predicted normal. One laboratory quoted a normal range. The normal values quoted showed an unacceptably wide variation between laboratories for several variables in Case 1, and for FEV1 in Case 2 (Table 2 ). In Case 1 this is partly due to error in one laboratory leading to the patient apparently having an acute attack of shortness of stature. In Case 2 the lowest value for predicted Fev1 is almost certainly a misprint. 35-38 29 In Case 1 bronchodilator response was tested in five laboratories by repeating the forced expiratory measurements. In one laboratory absolute lung volumes and RAW were also repeated and obvious decreases in hyperinflation and RAW were noted in the absence of a change in FEV1. FEV, increased by more than 0.1 litre on two occasions out of six.
Interpretation in Case 2 was relatively consistent, since a restrictive mechanical defect and a defect in gas transfer were uniformly detected. Two reports summarized the most striking numerical findings. All gave some functional interpretation, e.g. 'restrictive pattern'. Three stated that the findings were compatible with a diagnosis of sarcoidosis.
Case 1 was purposely selected as a good example of the applied respiratory physiologist's semantic nightmare. All reports gave some functional interpretation of results, and the interpretations were broadly similar, though varying in detail. The clinical diagnosis mentioned in the reports were as follows: intrinsic airways disease; chronic bronchitis, heart failure; asthma, heart failure; asthma, emphysema; asthma, emphysema (?? fibrosing alveolitis); no clinical diagnosis mentioned.
Dr Saunders in answer to Professor C M Fletcher said that only one laboratory out of six gave a range for the reference values. Dr J E Cotes thought it unsatisfactory that in relation to the diagnosis of emphysema no laboratory had measured the compliance of the lung or the recoil pressure. Dr Saunders said that not only was it not measured, but there was no written space for it on any of the report sheets. In answer to Dr M Green, Dr Saunders said that in patients with airways obstruction, no single number could be obtained for the airways resistance measured by the plethysmograph method. This was due to difficulties in interpreting the pressure-flow loop.
Dr G Laszlo (Respiratory Department, Bristol Royal Infirmary, Bristol, BS2 8HW) Investigation of Pulmonary Function: Current Practice in Ten Provincial British Laboratories Ten physicians responsible for respiratory investigation services answered a questionary about their practice in 1974-5 in the clinical investigation of individual patients. Three were from academic units, seven from routine hospital respiratory laboratories. Nearly all laboratories investigated each month about 25 patients who needed a clinical assessment as well as a numerical report. The numbers of patients referred for routine tests varied considerably; most of the reports were based on the numerical results. Tables 1 and 2 show the use made of certain tests.
Nine respondents agreed to comment on the results obtained from an actual patient, who had Static and dynamic lung compliance were each measured frequently by one and occasionally by six laboratories. FEV I = forced expired volume in one second; FVC = forced vital capacity; PEF = Wright peak flow meter; VC = vital capacity, unforced; RAW = airways resistance (body plethysmograph in all but one instance); MVV= 15 s maximum voluntary ventilation 0 more than once in two weeks The last line gives the number of patients tested in the laboratory under the direction of the respondent. One declined to comment on the information given.
* Professorial research laboratories severe bilateral emphysema, a,-antitrypsin deficiency and occasional attacks ot' bronchial asthma. The X-ray showed widespread pulmonary emphysema with large pulmonary arteries. The information provided was as follows: The reports provided are summarized in Table 3 , with all important ideas included. All reports began with a verbal description of the physiological findings, most diagnosed emphysema and five suggested or implied that there might be a reversible asthmatic component. The number of words used was inversely proportional to the number of reports written each month.
Dr Laszlo in answer to Dr T J H Clark and Dr R J Davies said that in eight out of ten laboratories, salbutamol was used for assessment of reversibility of airways obstruction; in six laboratories skin testing for atopic status was available for subjects showing a high degree of reversibility. Dr J E Cotes commented that the case of emphysema for I which results were presented by Dr Laszlo was typical of the advanced disease. In his view it was a disgrace that this diagnosis was not mentioned by four of the laboratories. Dr Laszlo replied that he found the standard of reporting astonishingly high; possibly his method of presenting the results had not done justice to those who had reported on them.
Mr T J Cole (MRC Pneumoconiosis Unit, Llandough Hospital, Penarth, South Glamorgan, CF6 IXW)
Height Standardization of Ventilatory Function
The equation widely used to height-standardize forced expiratory volume (FEV1) and forced vital capacity (FVC) over the last fifteen years is the multiple regression on age and height, FEV1=a,+ b1xage + c1xht +error A better alternative is provided by the new regression equation FEV1/ht2 = a2 + b2 x age + error which is termed proportional regression, and was validated by Cole (1975) .
The coefficients in the new equation come from the regression of FEV1/ht2 on age, and it provides just as good a fit to the data as multiple regression. Standardizing for height is particularly easy, since FEV1/ht2 does not correlate with height; correction to a standard -height Ho is achieved by multiplying by Ho2, thus FEV1 x (HO/ht)2 is standardized to height Ho. Standardization for age from the fitted regression line is the same as for multiple regression, except that the correction is made to FEV,/ht2. The age-standardized variable can then be multiplied to a standard height as required.
Besides its analytical advantages, proportional regression is valuable for inferring differences in respiratory health between populations. For example, groups of men from the town of Staveley, Derbyshire, with and without symptoms of breathlessness, provide multiple regression lines differing in intercept, age coefficient and height coefficient. (The difference in age coefficient is to be expected, but differing intercepts and height coefficients are difficult to interpret). The proportional regression lines are: FEV1/ht2 = 1.67-0.0131 age for men without symptoms (N= 684), and FEV1/ht2= 1.64-0.0155 age for those with (N= 175). Thus the new equation also gives differing slopes for age, but the intercepts are almost identical, showing that the difference between the groups in FEV,/ht2 is very small in early life, but increases with increasing age (Fig 1A) . The difference in health can be summarized by the hypothetical age at which the two lines predict a zero FEV1: 127 years for healthy men, but only 106 years for men with breathlessness, a highly significant difference (P<0.001). These ages are the ratio of the intercept and age slope in the equation, with reversed sign.
A second example concerns black and white workers in a New Orleans asbestos cement factory (Rossiter & Weill 1974) . They provide proportional regression lines of: FEV1= a1+ b, xage + cl xht +error for whites (N= 380), and FEV1/ht2 = a2+ b2x age +error for blacks: (N= 443) .
In this case the intercept as well as the slope is obviously smaller, indicating that at all ages blacks have a smaller predicted FEV1 than whites ( Fig  1B) . There is no reason to believe that the two groups differ in respiratory health, and blacks are widely held to have genetically smaller lung volumes than whites (Rossiter & Weill 1974) . Thus it might be expected that the two regression lines 
